New York State Common Retirement Fund’s Minerva Neurosciences NERV Stock Holding History

New York State Common Retirement Fund’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-33	Closed	-$1K	–	3463
2021 Q2	$1K	Sell	33 -3,167	-99%	-$68.2K	﹤0.01%	3436
2021 Q1	$75K	Hold	3,200	–	–	﹤0.01%	3136
2020 Q4	$60K	Hold	3,200	–	–	﹤0.01%	3164
2020 Q3	$81K	Hold	3,200	–	–	﹤0.01%	3018
2020 Q2	$92K	Hold	3,200	–	–	﹤0.01%	3017
2020 Q1	$154K	Hold	3,200	–	–	﹤0.01%	2585
2019 Q4	$182K	Hold	3,200	–	–	﹤0.01%	2777
2019 Q3	$198K	Hold	3,200	–	–	﹤0.01%	2783
2019 Q2	$144K	Hold	3,200	–	–	﹤0.01%	2971
2019 Q1	$201K	Hold	3,200	–	–	﹤0.01%	2720
2018 Q4	$173K	Hold	3,200	–	–	﹤0.01%	2770
2018 Q3	$321K	Hold	3,200	–	–	﹤0.01%	2615
2018 Q2	$211K	Hold	3,200	–	–	﹤0.01%	2845
2018 Q1	$160K	Hold	3,200	–	–	﹤0.01%	2825
2017 Q4	$155K	Hold	3,200	–	–	﹤0.01%	2865
2017 Q3	$195K	Sell	3,200 -313	-9%	-$18K	﹤0.01%	2785
2017 Q2	$249K	Buy	3,513 +1,350	+62%	+$87.4K	﹤0.01%	2735
2017 Q1	$140K	Hold	2,163	–	–	﹤0.01%	2885
2016 Q4	$203K	Hold	2,163	–	–	﹤0.01%	2764
2016 Q3	$244K	Buy	+2,163	New	+$210K	﹤0.01%	2685

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York State Common Retirement Fund's NERV Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of Minerva Neurosciences (NERV) in Q3 2021, closing a stake of 33 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in NERV in Q3 2016 and held it in 20 quarters. The position peaked at $321K in Q3 2018. 46 funds tracked by Wall St. Rank hold NERV as of Q3 2021.

New York State Common Retirement Fund reported no remaining Minerva Neurosciences position as of Q3 2021 after selling out during the quarter.
New York State Common Retirement Fund sold 33 Minerva Neurosciences shares in Q3 2021, an estimated $1K.
New York State Common Retirement Fund first reported a position in Minerva Neurosciences in Q3 2016 and held it in 20 quarters.
New York State Common Retirement Fund's Minerva Neurosciences position peaked at $321K in Q3 2018.
46 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.